capsid inhibitors (Roche Holding/Shanghai Lead Discovery Pharmaceuticals)

N/A

Report date: 2025/03/14 16:47:57
NME

Base Information

Drug Namecapsid inhibitors (Roche Holding/Shanghai Lead Discovery Pharmaceuticals)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionViral structural proteins inhibitors
TargetsViral structural proteins
Therapy Area/IndicationsHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerlandMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesRoche Holding Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Leadingtac Pharmaceutical Co LtdRoche Holding Ltd
Inactive CompaniesN/A
Active IndicationsHepatitis B
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A